CLINICAL TRIAL OF A NOVEL SPASMOLYTIC PRAMIVERINE AND ITS INFLUENCE ON COLITIS

dc.contributor.authorTOLEDO, GM
dc.date.accessioned2026-05-28T16:42:41Z
dc.date.issued1976
dc.description.paginacion731 - 732
dc.description.procedenciaEXT
dc.format.discursoArtículo
dc.format.extent2
dc.identifier.issn0004-4172
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/26793
dc.language.isoInglés
dc.numero.secuencia26790
dc.publisherSANATORIO DURANGO & ISSTE,MEXICO CITY,MEXICO
dc.relation.ispartofseriesVol. 26
dc.source.revistafuenteARZNEIMITTEL FORSCHUNG/DRUG RESEARCH
dc.subjectCLINICAL-TRIAL, NOVEL SPASMOLYTIC, PRAMIVERINE, INFLUENCE, COLITIS
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaCIENCIAS CLINICAS
dc.subject.subdisciplinaPATOLOGIA CLINICA
dc.titleCLINICAL TRIAL OF A NOVEL SPASMOLYTIC PRAMIVERINE AND ITS INFLUENCE ON COLITIS
dc.title.alternativeARZNEIM FORSCH DRUG RES

Files